Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as
Previous Article
BTC... 4202 ,62 ceD no natsikaP ni ec
Next Article
Rail... regrem SCK-PC morf emoc stifen